Openevidence deepens oncology push expands ai decision support cancer care

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 24 Sept, 12:07 UTC

The partnership builds on OpenEvidence's vision to develop “medical super-intelligence” based on agentic artificial intelligence, or a system of AI agents that can be subspecialists in clinical areas.